| 000 | 01583 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515182527.0 | ||
| 264 | 0 | _c20100106 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1520-7560 | ||
| 024 | 7 |
_a10.1002/dmrr.986 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiannini, Cosimo | |
| 245 | 0 | 0 |
_aTechnology and the issue of cost/benefit in diabetes. _h[electronic resource] |
| 260 |
_bDiabetes/metabolism research and reviews _cSep 2009 |
||
| 300 |
_aS34-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiotechnology _xtrends |
| 650 | 0 | 4 | _aBlood Glucose Self-Monitoring |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xeconomics |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMohn, Angelika | |
| 700 | 1 | _aChiarelli, Francesco | |
| 773 | 0 |
_tDiabetes/metabolism research and reviews _gvol. 25 Suppl 1 _gp. S34-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/dmrr.986 _zAvailable from publisher's website |
| 999 |
_c19069153 _d19069153 |
||